Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10Q Cash
For $1,000,000 the company could buy back and retire 100,000,000 shares, if such a large number is legal. That should add 33% to the stock price. I don't think run rate exceeds $1M a year excluding legal fees which ought to be covered by new license fees. Otherwise, why bother? It's past 2am here so apologies if my thoughts are wrong!
Share
New Message
Please login to post a reply